Literature DB >> 3922297

Peroxidase-mediated oxidation of isoniazid.

H A Shoeb, B U Bowman, A C Ottolenghi, A J Merola.   

Abstract

Oxidation of isonicotinic acid hydrazide (isoniazid) by horseradish peroxidase at the expense of H2O2 yielded reactive species which were able to reduce nitroblue tetrazolium and bleach p-nitrosodimethylaniline. Nicotinic acid hydrazide oxidation did not cause these effects. At slightly alkaline pH, oxidation of isonicotinic acid hydrazide by horseradish peroxidase proceeded at the expense of molecular O2, and the reaction was oxygen consuming. The addition of H2O2 abolished O2 consumption. Bovine liver catalase enhanced the rate of nitroblue tetrazolium reduction and decreased the maximal velocity of the reaction proportionately to catalase concentration. During oxidation of isonicotinic acid hydrazide by horseradish peroxidase-H2O2, splitting of the heme group of horseradish peroxidase took place as shown by the disappearance of the Soret and minor bands in the visible region of the spectrum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922297      PMCID: PMC176284          DOI: 10.1128/AAC.27.3.399

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Isonicotinic acid hypothesis of the antituberculous action of isoniazid.

Authors:  E THIEMER-KRUGER
Journal:  Am Rev Tuberc       Date:  1958-02

Review 2.  Detection of oxygen radicals in biological reactions.

Authors:  W Bors; M Saran; E Lengfelder; C Michel; C Fuchs; C Frenzel
Journal:  Photochem Photobiol       Date:  1978 Oct-Nov       Impact factor: 3.421

3.  The purification and properties of peroxidase in Mycobacterium tuberculosis H37Rv and its possible role in the mechanism of action of isonicotinic acid hydrazide.

Authors:  B G Devi; M S Shaila; T Ramakrishnan; K P Gopinathan
Journal:  Biochem J       Date:  1975-07       Impact factor: 3.857

4.  Oxidation of isonicotinic acid hydrazide by the peroxidase system. The formation of an excited product.

Authors:  K Zinner; C C Vidigal; N Durán; G Cilento
Journal:  Arch Biochem Biophys       Date:  1977-04-30       Impact factor: 4.013

5.  An enzyme system of Mycobacterium tuberculosis that reacts specifically with isoniazid. I.

Authors:  J Youatt; S H Tham
Journal:  Am Rev Respir Dis       Date:  1969-07

Review 6.  A review of the action of isoniazid.

Authors:  J Youatt
Journal:  Am Rev Respir Dis       Date:  1969-05

7.  Evidence of a hydrazine-reactive group at the active site of the nonheme portion of horseradish peroxidase.

Authors:  H Hidaka; S Udenfriend
Journal:  Arch Biochem Biophys       Date:  1970-09       Impact factor: 4.013

8.  Differentiation of catalases in Mycobacterium phlei on the basis of susceptibility to isoniazid: association with peroxidase and acquired resistance to isoniazid.

Authors:  W B Davis; D M Phillips
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

9.  Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.

Authors:  J K Seydel; K J Schaper; E Wempe; H P Cordes
Journal:  J Med Chem       Date:  1976-04       Impact factor: 7.446

10.  Enzymatic activation of hydrazine derivatives. A spin-trapping study.

Authors:  B K Sinha
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

View more
  20 in total

1.  Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.

Authors:  B Phetsuksiri; A R Baulard; A M Cooper; D E Minnikin; J D Douglas; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.

Authors:  Jonathan Paul Smith
Journal:  Yale J Biol Med       Date:  2011-12

3.  Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid.

Authors:  H A Shoeb; B U Bowman; A C Ottolenghi; A J Merola
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

4.  NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis.

Authors:  L Miesel; T R Weisbrod; J A Marcinkeviciene; R Bittman; W R Jacobs
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

5.  Detection of a novel catalase in extracts of Mycobacterium avium and Mycobacterium intracellulare.

Authors:  L G Wayne; G A Diaz
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.

Authors:  N M Parrish; T Houston; P B Jones; C Townsend; J D Dick
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra.

Authors:  H A Shoeb; B U Bowman; A C Ottolenghi; A J Merola
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

8.  Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 A resolution.

Authors:  Amit K Singh; Ramasamy P Kumar; Nisha Pandey; Nagendra Singh; Mau Sinha; Asha Bhushan; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  J Biol Chem       Date:  2009-11-11       Impact factor: 5.157

9.  Mechanism of horseradish peroxidase inactivation by benzhydrazide: a critical evaluation of arylhydrazides as peroxidase inhibitors.

Authors:  Susan M Aitken; Marc Ouellet; M David Percival; Ann M English
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

10.  Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.

Authors:  B Heym; Y Zhang; S Poulet; D Young; S T Cole
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.